MARCKS is a New Prognostic Biomarker in Hepatocellular Carcinoma

MARCKS is a New Prognostic Biomarker in Hepatocellular Carcinoma

Haoran Lu,1,&ast; Rou Zhao,2,&ast; Qianqian Qin,3 Liyong Tang,1 Guodong Ma,1 Baoyu He,2 Jing Liang,2 Li Wei,2 Xutong Wang,2 Qingli Bie,2 Xuning Wang,4 Bin Zhang2,5 1Department of Hepatobiliary Surgery, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shand...

Full description

Bibliographic Details
Main Authors:	Lu H, Zhao R, Qin Q, Tang L, Ma G, He B, Liang J, Wei L, Wang X, Bie Q, Zhang B
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-05-01
Series:	International Journal of General Medicine
Subjects:	myristoylated alanine-rich c-kinase substrate hcc tcga prognostic value
Online Access:	https://www.dovepress.com/marcks-is-a-new-prognostic-biomarker-in-hepatocellular-carcinoma-peer-reviewed-fulltext-article-IJGM

Similar Items

Identification of the hub and prognostic genes in liver hepatocellular carcinoma via bioinformatics analysis
by: Qiannan Gao, et al.
Published: (2022-09-01)

Identification of Inflammatory Proteomics Networks of Toll-like Receptor 4 through Immunoprecipitation-Based Chemical Cross-Linking Proteomics
by: A. D. A. Shahinuzzaman, et al.
Published: (2022-09-01)

Role of NCF2 as a potential prognostic factor and immune infiltration indicator in hepatocellular carcinoma
by: Ning Huang, et al.
Published: (2023-04-01)

Identification of four prognostic LncRNAs for survival prediction of patients with hepatocellular carcinoma
by: Zhonghao Wang, et al.
Published: (2017-07-01)

Identification of tumor antigens and anoikis-based molecular subtypes in the hepatocellular carcinoma immune microenvironment: implications for mRNA vaccine development and precision treatment
by: Zhiyuan Zheng, et al.
Published: (2023-08-01)

MUTYH is a potential prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma
by: Fan Yang, et al.
Published: (2022-12-01)

NF-Y Overexpression in Liver Hepatocellular Carcinoma (HCC)
by: Eugenia Bezzecchi, et al.
Published: (2020-12-01)

Macroscopic Characterization of Hepatocellular Carcinoma: An Underexploited Source of Prognostic Factors
by: Gonvers S, et al.
Published: (2024-04-01)

Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma
by: Feng Xue, et al.
Published: (2020-05-01)

Prognostic model of AU-rich genes predicting the prognosis of lung adenocarcinoma
by: Yong Liu, et al.
Published: (2021-10-01)

Prognostic and immune correlation evaluation of a novel cuproptosis-related genes signature in hepatocellular carcinoma
by: Zheng Zhou, et al.
Published: (2022-12-01)

Construction of a Prognostic Signature of 10 Autophagy-Related lncRNAs in Gastric Cancer
by: Wang W, et al.
Published: (2022-04-01)

Myristoyl’s dual role in allosterically regulating and localizing Abl kinase
by: Svenja de Buhr, et al.
Published: (2023-10-01)

Bioinformatics prediction and experimental verification identify cuproptosis-related lncRNA as prognosis biomarkers of hepatocellular carcinoma
by: Zhu Liangyu, et al.
Published: (2023-09-01)

Identification of Anoikis-Related Subgroups and Prognosis Model in Liver Hepatocellular Carcinoma
by: Yutong Chen, et al.
Published: (2023-02-01)

LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma
by: Hongbin Zhang, et al.
Published: (2022-01-01)

Construction and validation of a prognostic model of pyroptosis related genes in hepatocellular carcinoma
by: Guanqun Li, et al.
Published: (2022-10-01)

The Prognostic Significance of the TEAD4 in Hepatocellular Carcinoma
by: Lei L, et al.
Published: (2023-12-01)

Src family kinases engage differential pathways for encapsulation into extracellular vesicles
by: Chenming Ye, et al.
Published: (2023-06-01)

Integrated Analysis of N1-Methyladenosine Methylation Regulators-Related lncRNAs in Hepatocellular Carcinoma
by: Danjun Song, et al.
Published: (2023-03-01)

Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio Predicts Prognosis of Hepatocellular Carcinoma in Patients with Metabolic-Associated Fatty Liver Disease
by: Miao T, et al.
Published: (2024-01-01)

DHRS7 is an immune-related prognostic biomarker of KIRC and pan-cancer
by: Sheng Tang, et al.
Published: (2022-10-01)

Screening and validation of prognostic indicator genes in the progression of HBV related hepatocellular carcinoma
by: Jinglin Wang, et al.
Published: (2023-03-01)

PUS1 May Be a Potential Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma
by: Lan C, et al.
Published: (2023-04-01)

Prognostic Analysis and Biomarkers Identification of Immune Infiltration in Early and Late Stage Hepatocellular Carcinoma Based on TCGA Data
by: Jiang W, et al.
Published: (2023-06-01)

Identification of the cuproptosis-related molecular subtypes and an immunotherapy prognostic model in hepatocellular carcinoma
by: Li Zhang, et al.
Published: (2022-11-01)

RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers
by: Zhouting Tuo, et al.
Published: (2022-05-01)

Identification of hub genes associated with hepatitis B virus-related hepatocellular cancer using weighted gene co-expression network analysis and protein-protein interaction network analysis
by: Wenze Wu, et al.
Published: (2023-09-01)

GNL3 and PA2G4 as Prognostic Biomarkers in Prostate Cancer
by: Shashank Kumar, et al.
Published: (2023-05-01)

A Multi-Omics Analysis of NASH-Related Prognostic Biomarkers Associated with Drug Sensitivity and Immune Infiltration in Hepatocellular Carcinoma
by: Yongting Liu, et al.
Published: (2023-02-01)

A lipid metabolism–based prognostic risk model for HBV–related hepatocellular carcinoma
by: Lili Zhou, et al.
Published: (2023-04-01)

A novel prognostic prediction model of cuprotosis-related genes signature in hepatocellular carcinoma
by: Ruo-Nan Shao, et al.
Published: (2023-08-01)

Kahweol Induces Apoptosis in Hepatocellular Carcinoma Cells by Inhibiting the Src/mTOR/STAT3 Signaling Pathway
by: Hye-Young Seo, et al.
Published: (2021-09-01)

Identification of a Novel Prognostic Signature Based on N-Linked Glycosylation and Its Correlation with Immunotherapy Response in Hepatocellular Carcinoma
by: Lin SS, et al.
Published: (2023-10-01)

New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma
by: Monica Mossenta, et al.
Published: (2019-07-01)

Construction and validation of prognostic signature for hepatocellular carcinoma basing on hepatitis B virus related specific genes
by: Lei Wang, et al.
Published: (2022-12-01)

Exploring prognostic microbiota markers in patients with endometrial carcinoma: Intratumoral insights
by: Jie Liu, et al.
Published: (2024-03-01)

A novel hypoxia-associated gene signature for prognosis prediction in head and neck squamous cell carcinoma
by: Jingyi Luo, et al.
Published: (2023-11-01)

Systematic analysis of the role of LDHs subtype in pan-cancer demonstrates the importance of LDHD in the prognosis of hepatocellular carcinoma patients
by: Shengnan Wang, et al.
Published: (2024-01-01)

Bioinformatics-driven identification of prognostic biomarkers in kidney renal clear cell carcinoma
by: Varinder Madhav Verma, et al.
Published: (2024-04-01)